These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1987692)

  • 21. The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction.
    Salerno A; Bonanno CT; Caccamo N; Cigna D; Dominici R; Ferro C; Sireci G; Dieli F
    Clin Exp Immunol; 1998 Apr; 112(1):112-9. PubMed ID: 9566798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge.
    Lorber MI; Wilson JH; Harding MW; Gromkowski S; Marks WH
    Transplantation; 1991 Jul; 52(1):167-70. PubMed ID: 1713364
    [No Abstract]   [Full Text] [Related]  

  • 23. Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplantation; 1991 Apr; 51(4):851-7. PubMed ID: 2014542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus.
    Combates NJ; Degiannis D; Raskova J; Raska K
    Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.
    Sigal NH; Lin CS; Siekierka JJ
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132
    [No Abstract]   [Full Text] [Related]  

  • 26. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.
    Ferron GM; Pyszczynski NA; Jusko WJ
    Transplantation; 1998 May; 65(9):1203-9. PubMed ID: 9603169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.
    Orosz CG; Adams PW; Ferguson RM
    Transplantation; 1988 Aug; 46(2 Suppl):73S-79S. PubMed ID: 2970141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
    J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive effect of bactobolamine on in vitro lymphocyte alloactivation: synergism with cyclosporine.
    Imai T; Inoue S; Kuzuhara K; Hosoya Y; Honda M; Takasaki E; Yoshida KI; Manaka K; Nishimura Y; Bekku Y; Tomikawa S; Nagao T; Uchida H
    Transplant Proc; 2000 Nov; 32(7):2060-2. PubMed ID: 11120066
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar.
    Kahan BD; Chou T; Tejpal N; Wang M; Chee C; Stepkowski S
    Transplant Proc; 1994 Oct; 26(5):3021-4. PubMed ID: 7940951
    [No Abstract]   [Full Text] [Related]  

  • 35. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.
    Schuurman HJ; Cottens S; Fuchs S; Joergensen J; Meerloo T; Sedrani R; Tanner M; Zenke G; Schuler W
    Transplantation; 1997 Jul; 64(1):32-5. PubMed ID: 9233697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine and the immune response: basic aspects.
    Hess AD; Colombani PM; Esa AH
    Crit Rev Immunol; 1986; 6(2):123-49. PubMed ID: 2942335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species- and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays.
    Ferron GM; Jusko WJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):191-200. PubMed ID: 9655860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
    Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
    Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporin A and G inhibition of cytokine production.
    Szturm K; Jeffery JR; Rush DN; McKenna RM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):857. PubMed ID: 2705251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.